Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis

Lauren Banner; Thomas Z Rohan; Rachel Zachian; Tyler Gross; Henry Y Yang; Daniel Joffe; Pierluigi Porcu; Neda Nikbakht

doi:10.1016/j.jaad.2024.03.013

Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis

J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505-X. doi: 10.1016/j.jaad.2024.03.013. Online ahead of print.

Authors

Lauren Banner¹, Thomas Z Rohan¹, Rachel Zachian², Tyler Gross¹, Henry Y Yang¹, Daniel Joffe¹, Pierluigi Porcu³, Neda Nikbakht⁴

Affiliations

¹ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA.
² Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA; Department of Medicine, Lankenau Medical Center, Wynnewood, PA.
³ Division of Hematologic Malignancies and Cellular Therapy, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
⁴ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA. Electronic address: Neda.nikbakht@jefferson.edu.

PMID: 38513830
DOI: 10.1016/j.jaad.2024.03.013

No abstract available

Keywords: bladder cancer; epidemiology end results (SEER); lung cancer; melanoma; primary cutaneous B-cell lymphoma (PCBCL); prostate cancer; renal cancer; second primary malignancy (SPM); surveillance; thyroid cancer.